
Publications
A universal dual mechanism immunotherapy for the treatment of influenza virus infections
Xin Liu, Boning Zhang, Yingcai Wang, Hanan S. Haymour, Fenghua Zhang, Le-cun Xu, Madduri Srinivasarao, and Philip S. Low
Nature Communications, 2020
Principles in the design of ligand targeted cancer therapeutics and imaging agents
Madduri Srinivasarao, Chris V. Galliford, and Philip S. Low
Nature Reviews Drug Discovery, February 2015
Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate–targeted immunotherapy in hapten-immunized mice
Yingjuan Lu, Le-Cun Xu, Nikki Parker, Elaine Westrick, Joseph A. Reddy, Marilynn Vetzel, Philip S. Low, and Christopher P. Leamon
Molecular Cancer Therapeutics, December 2006
Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential
Yingjuan Lu, Fei You, Iontcho Vlahov, Elaine Westrick, Mingjin Fan, Philip S. Low, and Christopher P. Leamon
Molecular Pharmaceutics, 2007
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
Yong Gu Lee, Haiyan Chu, Yingjuan Lu, Christopher P. Leamon, Madduri Srinivasarao, Karson S. Putt, and Philip S. Low
Nature Communications, 2019